Antengene Corporation Revenue

Antengene Corporation had revenue of 53.18M CNY in the half year ending June 30, 2025, a decrease of -26.15%. This brings the company's revenue in the last twelve months to 84.35M, up 50.45% year-over-year. In the year 2024, Antengene Corporation had annual revenue of 91.95M with 36.62% growth.

Revenue (ttm)

84.35M CNY

Revenue Growth

+50.45%

P/S Ratio

29.39

Revenue / Employee

554.95K CNY

Employees

152

Market Cap

2.72B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	91.95M	24.65M	36.62%
Dec 31, 2023	67.31M	-92.83M	-57.97%
Dec 31, 2022	160.14M	131.37M	456.62%
Dec 31, 2021	28.77M	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Recbio Technology	31.90M
SinoMab BioScience	6.28M
Clover Biopharmaceuticals	56.73M
BioDlink International Company	1.17B
Frontage Holdings	1.99B
Medtide	546.29M
Hangzhou Jiuyuan Genetic Biopharmaceutical	1.43B
AIM Vaccine	1.38B

Revenue Rankings

Antengene Corporation News

2 months ago - Antengene Secures Malaysian Approval For XPOVIO In Relapsed/Refractory DLBCL - Nasdaq
3 months ago - Antengene: NMPA Approves IND Application For Phase Ib/II CLINCH-2 Study With ATG-022 - Nasdaq

More News